Does LENALIDOMIDE Cause Progressive multifocal leukoencephalopathy? 202 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 202 reports of Progressive multifocal leukoencephalopathy have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.1% of all adverse event reports for LENALIDOMIDE.
202
Reports of Progressive multifocal leukoencephalopathy with LENALIDOMIDE
0.1%
of all LENALIDOMIDE reports
96
Deaths
85
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From LENALIDOMIDE?
Of the 202 reports, 96 (47.5%) resulted in death, 85 (42.1%) required hospitalization, and 42 (20.8%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
Yes, Progressive multifocal leukoencephalopathy is listed as a known adverse reaction in the official FDA drug label for LENALIDOMIDE.
What Other Side Effects Does LENALIDOMIDE Cause?
Diarrhoea (27,576)
Fatigue (22,956)
Death (19,213)
Off label use (17,017)
Rash (15,794)
Pneumonia (14,807)
Plasma cell myeloma (14,191)
Neuropathy peripheral (10,215)
White blood cell count decreased (9,996)
Constipation (9,635)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which LENALIDOMIDE Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
LENALIDOMIDE vs LENIOLISIB
LENALIDOMIDE vs LENOGRASTIM
LENALIDOMIDE vs LENVATINIB
LENALIDOMIDE vs LEPONEX
LENALIDOMIDE vs LERCANIDIPINE